1.39
前日終値:
$1.37
開ける:
$1.36
24時間の取引高:
1.67M
Relative Volume:
0.60
時価総額:
$98.84M
収益:
$391.70K
当期純損益:
$-52.34M
株価収益率:
-1.8533
EPS:
-0.75
ネットキャッシュフロー:
$-45.92M
1週間 パフォーマンス:
-14.72%
1か月 パフォーマンス:
+6.92%
6か月 パフォーマンス:
+324.95%
1年 パフォーマンス:
+23.01%
Ovid Therapeutics Inc Stock (OVID) Company Profile
名前
Ovid Therapeutics Inc
セクター
電話
212-776-4381
住所
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
OVID を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
OVID
Ovid Therapeutics Inc
|
1.39 | 97.42M | 391.70K | -52.34M | -45.92M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-09 | 開始されました | Oppenheimer | Outperform |
| 2025-08-08 | 再開されました | B. Riley Securities | Buy |
| 2024-06-18 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-04-30 | 開始されました | B. Riley Securities | Buy |
| 2024-04-29 | 開始されました | H.C. Wainwright | Buy |
| 2024-04-05 | 開始されました | Wedbush | Outperform |
| 2023-12-21 | 開始されました | BTIG Research | Buy |
| 2023-10-13 | 開始されました | Oppenheimer | Outperform |
| 2021-04-20 | ダウングレード | Cantor Fitzgerald | Buy → Neutral |
| 2021-03-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-02 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-04 | 開始されました | RBC Capital Mkts | Outperform |
| 2018-04-20 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Ovid Therapeutics Inc (OVID) 最新ニュース
Can trapped investors hope for a rebound in Ovid Therapeutics Inc.2025 Technical Overview & Safe Capital Growth Tips - newser.com
How Ovid Therapeutics Inc. (1OT) stock correlates with oil markets2025 Price Action Summary & Fast Entry and Exit Trade Plans - newser.com
Combining machine learning predictions for Ovid Therapeutics Inc.Watch List & Technical Buy Zone Confirmation - newser.com
Visual analytics tools that track Ovid Therapeutics Inc. performanceM&A Rumor & Risk Managed Investment Entry Signals - newser.com
Is Ovid Therapeutics Inc. stock a safe haven assetWeekly Gains Summary & Scalable Portfolio Growth Methods - newser.com
Long term hold vs stop loss in Ovid Therapeutics Inc.July 2025 Spike Watch & Real-Time Volume Spike Alerts - newser.com
What MACD trends signal for Ovid Therapeutics Inc. (1OT) stockQuarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com
Is Ovid Therapeutics Inc. (1OT) stock protected from inflation2025 Breakouts & Breakdowns & Safe Entry Zone Tips - newser.com
How strong is Ovid Therapeutics Inc. stock balance sheetJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - newser.com
Using flow based indicators on Ovid Therapeutics Inc.Market Performance Summary & AI Driven Price Forecasts - newser.com
Short Interest in Ovid Therapeutics (NASDAQ:OVID) Grows By 463.2% - MarketBeat
Ovid Therapeutics (OVID) Price Target Increased by 22.06% to 4.23 - Nasdaq
Quarterly Recap: How Ovid Therapeutics Inc. stock compares to industry benchmarksEarnings Summary Report & Weekly Sector Rotation Insights - fcp.pa.gov.br
OVID PRE 14A: approvals for Series B conversion and warrants - Stock Titan
OVID special meeting to approve PIPE share issuances and 315M authorization - Stock Titan
Ovid Therapeutics Inc (OVID) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):